Are you Dr. Hoverson Schott?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1000 S Columbia Rd
Grand Forks, ND 58201Phone+1 701-780-5000Fax+1 701-780-1942
Summary
- Dr. Alyssa (Hoverson) Hoverson Schott, MD is a board certified dermatologist in Grand Forks, North Dakota. She is currently licensed to practice medicine in North Dakota, Arizona, and Minnesota. She is affiliated with Altru Health System and Sanford Medical Center Fargo.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2006 - 2009
- University of North DakotaInternship, Transitional Year, 2005 - 2006
- University of North Dakota School of Medicine and Health SciencesClass of 2005
Certifications & Licensure
- MN State Medical License 2006 - 2025
- ND State Medical License 2005 - 2025
- AZ State Medical License 2008 - 2009
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 10 citationsMultiple squamous cell carcinomas in the setting of psoriasis treated with etanercept: a report of four cases and review of the literature.Jerry D. Brewer, Alyssa R. Hoverson Schott, Randall K. Roenigk
International Journal of Dermatology. 2011-12-01 - 38 citationsThe use of oral midazolam for perioperative anxiolysis of healthy patients undergoing Mohs surgery: conclusions from randomized controlled and prospective studies.Larisa Ravitskiy, Pamela K. Phillips, Randall K. Roenigk, Amy L. Weaver, Jill M. Killian
Journal of the American Academy of Dermatology. 2011-02-01 - 26 citationsNeutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide.Alyssa R. Hoverson, Mark D. P. Davis, Roger H. Weenig, Alexandra P. Wolanskyj
Archives of Dermatology. 2006-08-01